Recently, emerging data suggest that different RAGE-dependent mechanism may have direct therapeutic implications in the therapeutic response to antineoplastic therapy of cancer patients, which highlights the crucial role of the AGE/RAGE axis in the development of cancer cells as well as in the survival of cancer patients [201]. This evidence concerns the gene AGER and cancer.